Point72 Hong Kong Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 197 filers reported holding HAEMONETICS CORP in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2022$225,000
-63.4%
3,445
-37.8%
0.01%
-61.9%
Q1 2021$615,000
+128.6%
5,541
+79.4%
0.02%
-27.6%
Q3 2020$269,000
+171.7%
3,088
+257.4%
0.03%
+26.1%
Q4 2019$99,000
-23.8%
864
-16.4%
0.02%
-37.8%
Q3 2019$130,000
+4233.3%
1,034
+2694.6%
0.04%
+3600.0%
Q1 2019$3,000
-95.5%
37
-95.0%
0.00%
-95.7%
Q2 2018$67,000
+458.3%
747
+352.7%
0.02%
+283.3%
Q1 2018$12,000
+9.1%
165
-11.3%
0.01%
-25.0%
Q4 2017$11,000
-15.4%
186
-43.5%
0.01%
-42.9%
Q2 2017$13,000
-40.9%
329
-45.2%
0.01%
+16.7%
Q3 2016$22,0006000.01%
Other shareholders
HAEMONETICS CORP shareholders Q4 2016
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders